PAREXEL develops several new patient-centric solutions to address drug development

PAREXEL International Corporation, a leading innovator of global biopharmaceutical services, today announced that it has developed several new solutions that take a patient-centric approach to addressing drug development.

Built on the Perceptive® Cloud platform and leveraging PAREXEL’s relationship with Microsoft, the solutions incorporate mobile and wearable technology to increase access to data and improve the patient experience in clinical research.

The first solution is designed to enable health care staff and first line clinicians to communicate time-sensitive events to study staff.

Leveraging Microsoft Azure App Services, the technology will generate health alerts through data transmission from mobile devices, gathered at the patient home or in the field and forwarded automatically whenever there is connectivity.

Staff and investigators will then be automatically informed and could pro-actively address any threat to patient safety, potentially decreasing risk of patient mortality and morbidity.

PAREXEL has also initiated several projects that expand innovation in the application of mobile medical devices in clinical trials.

Specifically, PAREXEL’s Patient Sensor Solution capabilities now include an expanded list of connected medical devices, and integrations with DataLabs®, PAREXEL’s electronic data capture technology and ClinPhone® RTSM, PAREXEL’s interactive response solution for randomization and trial supplies management.

The Sensor Solution utilizes advanced Artificial Intelligence (AI) technology to support predictive monitoring of patient compliance and has been expanded to manage larger volumes of data transfer.

Technology has made it possible to access more meaningful data than ever  before,  while improving the patient experience. The challenge is in collecting that data in a way that is efficient for the patient, site, and investigator.

PAREXEL has always been committed to helping our clients solve their most difficult challenges and applying both our innovative technology development and strategic alliance capabilities to provide seamless, patient-centric solutions to benefit our customers and their patients.”

Douglas Barta, Chief Information Officer, PAREXEL

The solutions are all built on Perceptive Cloud, a cloud solution offered by PAREXEL and designed to deliver cost-effective innovation while safeguarding sensitive information.

The solutions were developed in collaboration with Microsoft and integrate cloud services including Microsoft Azure IoT Hub and Azure Stream Analytics.

Clinical development is an area ripe for digital transformation, and industry leaders like PAREXEL are integrating Microsoft Azure into their solutions to help do just that. Through this collaboration, we can reduce costs, make services more efficient, and in turn, provide better care to patients.”

Chris Sakalosky, Microsoft

Microsoft will join PAREXEL at its HORIZONS conference to discuss how these and other innovations are driving digital transformation and patient centricity.

HORIZONS is an annual conference hosted by PAREXEL taking place October 15-18, 2018 in Washington, DC.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Parexel. (2023, February 21). PAREXEL develops several new patient-centric solutions to address drug development. News-Medical. Retrieved on July 20, 2024 from https://www.news-medical.net/news/20181010/PAREXEL-develops-several-new-patient-centric-solutions-to-address-drug-development.aspx.

  • MLA

    Parexel. "PAREXEL develops several new patient-centric solutions to address drug development". News-Medical. 20 July 2024. <https://www.news-medical.net/news/20181010/PAREXEL-develops-several-new-patient-centric-solutions-to-address-drug-development.aspx>.

  • Chicago

    Parexel. "PAREXEL develops several new patient-centric solutions to address drug development". News-Medical. https://www.news-medical.net/news/20181010/PAREXEL-develops-several-new-patient-centric-solutions-to-address-drug-development.aspx. (accessed July 20, 2024).

  • Harvard

    Parexel. 2023. PAREXEL develops several new patient-centric solutions to address drug development. News-Medical, viewed 20 July 2024, https://www.news-medical.net/news/20181010/PAREXEL-develops-several-new-patient-centric-solutions-to-address-drug-development.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
CenterWatch 2017 Global Investigative Site Relationship Survey ranks PAREXEL among top five CROs